Press release

Kaiseraugst, CH, 18 Mar 2015 13:30 CET

Following recent market concerns about quality of certain sources of Vitamin B2, demand for Rovimix® B2 80 SD from DSM has increased significantly. In response to this market need, DSM will be investing to expand the production capacity of its Grenzach, Germany B2 facility. It is expected that the new capacity will be available in 2016, further strengthening DSM’s leadership position for this important vitamin.

DSM has strict Quality Assurance procedures and ensures that Rovimix B2 80 SD is fully compliant with the regulations of Europe and all other markets worldwide.